Cargando…

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma

BACKGROUND: Thrombocytopenia is a significant problem in patients with relapsed or refractory multiple myeloma, precipitating a need for supportive platelet transfusions and necessitating decreases in delivered doses of chemotherapy. Eltrombopag is a non-peptide, small molecule thrombopoietin (TPO)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Jee-Yeong, Levine, Michelle S, Abayasekara, Nirmalee, Berliner, Nancy, Laubach, Jacob, Vanasse, Gary J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405817/ https://www.ncbi.nlm.nih.gov/pubmed/25886818 http://dx.doi.org/10.1186/s13045-015-0136-2

Ejemplares similares

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
por: Erickson-Miller, Connie L, et al.
Publicado: (2009)

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
por: Evstatiev, Rayko, et al.
Publicado: (2014)

The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
por: Vogel, Jens-Uwe, et al.
Publicado: (2019)

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
por: Plo, Isabelle, et al.
Publicado: (2017)

Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
por: Gostynska, Sandra, et al.
Publicado: (2022)

Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma
por: Kuang, Chunmei, et al.
Publicado: (2023)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
por: Hou, Ming
Publicado: (2021)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
por: Shin, Jiwon, et al.
Publicado: (2023)

Switching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study
por: Cai, Xuan, et al.
Publicado: (2022)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)

Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients
por: Di Buduo, Christian A, et al.
Publicado: (2021)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
por: Zhu, Qiuhua, et al.
Publicado: (2021)

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)

Role of Rho-GTPases in megakaryopoiesis
por: Vainchenker, William, et al.
Publicado: (2021)

Bone Marrow Osteoblastic Niche: A New Model to Study Physiological Regulation of Megakaryopoiesis
por: Pallotta, Isabella, et al.
Publicado: (2009)

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
por: Zhang, Ke, et al.
Publicado: (2018)

Novel function of FAXDC2 in megakaryopoiesis
por: Jin, Q, et al.
Publicado: (2016)

Inside-to-outside and back to the future of megakaryopoiesis
por: Di Buduo, Christian Andrea, et al.
Publicado: (2023)

PB2425: EFFICACY AND SAFETY OF COMBINED THERAPY OF RECOMBINANT HUMAN THROMBOPOIETIN AND ELTROMBOPAG FOR TREATMENT OF PERSISTENT THROMBOCYTOPENIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Pan, Pan, et al.
Publicado: (2023)

A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
por: Khan, Meaghan, et al.
Publicado: (2010)

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
por: González-Porras, José R., et al.
Publicado: (2019)

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
por: Gilreath, Jeffrey, et al.
Publicado: (2021)

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Suppressive Effects of Anthrax Lethal Toxin on Megakaryopoiesis
por: Chen, Po-Kong, et al.
Publicado: (2013)

A Mad(2) modification modulating megakaryopoiesis
por: Goldfarb, Adam
Publicado: (2014)

Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever?
por: Roy, Sayak
Publicado: (2019)

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
por: Agarwal, Nikki, et al.
Publicado: (2021)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021)

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists
por: Drillet, Gaëlle, et al.
Publicado: (2022)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
por: van de Donk, Niels WCJ, et al.
Publicado: (2012)

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib
por: Richardson, Paul G, et al.
Publicado: (2017)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
por: Chang, Hong, et al.
Publicado: (2023)

Transcription factors in late megakaryopoiesis and related platelet disorders
por: Tijssen, M R, et al.
Publicado: (2013)

Dual role of IL-21 in megakaryopoiesis and platelet homeostasis
por: Benbarche, Salima, et al.
Publicado: (2017)

TFII-I/Gtf2i and Erythro-Megakaryopoiesis
por: Gurumurthy, Aishwarya, et al.
Publicado: (2020)

Microbiota-Derived Propionate Modulates Megakaryopoiesis and Platelet Function
por: Dürholz, Kerstin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrd5enta1123roc713jdh2jvr4